Randomized Crossover Trial to Assess the Tolerability of GnRH Analogue Administration in Patients With Advanced Prostate Cancer.
Phase of Trial: Phase IV
Latest Information Update: 05 Sep 2013
At a glance
- Drugs Leuprorelin (Primary) ; Triptorelin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Actavis Inc
- 01 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jul 2010 New trial record